{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:00:14Z","timestamp":1790870414409,"version":"4.1.0"},"reference-count":6,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1182\/blood.2026035382","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:33:47Z","timestamp":1790868827000},"page":"1761-1762","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Measuring factor VIII after gene therapy: which assay?"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-9062","authenticated-orcid":false,"given":"Michiel","family":"Coppens","sequence":"first","affiliation":[{"name":"Amsterdam UMC"},{"name":"Amsterdam Cardiovascular Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"14","key":"2026100111333800800_bib1","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.2025032890","article-title":"One-stage assay factor VIII activity reflects AAV-derived factor VIII\u2013enhanced thrombin activation and predicts phenotype","volume":"148","author":"Sternberg","year":"2026","journal-title":"Blood"},{"issue":"2","key":"2026100111333800800_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jth.13215","article-title":"A critical appraisal of one-stage and chromogenic assays of factor VIII activity","volume":"14","author":"Peyvandi","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2026100111333800800_bib3","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jtha.2026.04.017","article-title":"Correlation between factor VIII chromogenic activity and antigen levels in patients treated with adeno-associated virus 5-mediated gene therapy for hemophilia A","volume":"24","author":"Peyvandi","year":"2026","journal-title":"J Thromb Haemost"},{"key":"2026100111333800800_bib4","unstructured":"BioMarin\n          . BioMarin Voluntarily Withdraws ROCTAVIAN\u00ae (valoctocogene roxaparvovec-rvox) from the Market. 23 February 2026. Accessed 12 August 2026. http:\/\/biomarin.com\/news\/company-statements\/biomarin-voluntarily-withdraws-roctavian-from-the-market\/."},{"issue":"3","key":"2026100111333800800_bib5","doi-asserted-by":"crossref","first-page":"103416","DOI":"10.1016\/j.rpth.2026.103416","article-title":"Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results","volume":"10","author":"Leavitt","year":"2026","journal-title":"Res Pract Thromb Haemost"},{"key":"2026100111333800800_bib6","unstructured":"ISTH News\n          . Critical Juncture in Hemophilia Treatment: Global Organizations Issue Urgent Call to Action. International Society on Thrombosis and Haemostasis. Accessed 5 July 2026. https:\/\/www.isth.org\/news\/699516\/."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/14\/1761\/2593339\/blood_bld-2026-035382-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/14\/1761\/2593339\/blood_bld-2026-035382-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:33:49Z","timestamp":1790868829000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/14\/1761\/571118\/Measuring-factor-VIII-after-gene-therapy-which"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":6,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026035382","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,1]]},"published":{"date-parts":[[2026,10,1]]}}}